View in EDS PDF Full Text

Diabetes gestacional. Una revisión sistemática.

Saved in:
Bibliographic Details
Title: Diabetes gestacional. Una revisión sistemática.
Alternate Title: Gestational diabetes. A systematic review.
Authors: Robles Granda, Eliana1, Domo Tomalá, Doris2, Chango Ramírez, Ángel1, Estrada García, Lady1, Yugcha Andino, Germania1, Calderón León, María Fernanda3 dracalderonleon@hotmail.es
Source: Revista Medicina. 2025, Vol. 25 Issue 1, p14-21. 8p.
Subjects: TYPE 2 diabetes, GESTATIONAL diabetes, NEONATAL intensive care units, TYPE 1 diabetes, WEIGHT gain
Abstract (English): Introduction: Gestational diabetes, a common disease in pregnancy, whose prevalence increases in one in six live births worldwide. Materials and methods: A systematic review was developed with the PRISMA 2020 declaration. Results: metformin was superior to insulin in hypoglycemic events. The efficacy, safety of metformin alone or as complementary insulin therapy in pregnancy with gestational diabetes mellitus with diabetes mellitus type 2 reduced maternal weight gain, maternal hypoglycemia, neonatal hypoglycemia, admission to the neonatal intensive care unit and reduction of birth weight 4000 g. Conclusions: Gestational diabetes is related to perinatal morbidity, an increased risk of diabetes and cardiovascular diseases in the future mother and predisposition to childhood obesity in offspring. Metformin reduces the risk of certain maternal and neonatal outcomes compared to insulin therapy [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Introducción: La diabetes gestacional, enfermedad frecuente en el embarazo, cuya prevalencia aumenta en uno de cada seis nacidos vivos en todo el mundo. Materiales y métodos: Se elaboró una revisión sistemática con la declaración PRISMA 2020. Resultados: metformina fue superior a la insulina en eventos hipoglucémicos. La eficacia, seguridad de la metformina sola o como terapia complementaria a la insulina en el embarazo con diabetes mellitus gestacional con diabetes mellitus tipo 2 redujo el aumento de peso materno, hipoglucemia materna, hipoglucemia neonatal, ingreso a la unidad de cuidados intensivos neonatales y reducción del peso al nacer ≥4000 g. Conclusiones: La Diabetes gestacional se relaciona con morbilidad perinatal, un mayor riesgo de diabetes y enfermedades cardiovasculares en la madre a futuro y predisposición a obesidad infantil en la descendencia. La metformina reduce el riesgo de ciertos resultados maternos y neonatales en comparación con la terapia con insulina. [ABSTRACT FROM AUTHOR]
Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 186116458
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Diabetes gestacional. Una revisión sistemática.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Gestational diabetes. A systematic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Robles+Granda%2C+Eliana%22">Robles Granda, Eliana</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Domo+Tomalá%2C+Doris%22">Domo Tomalá, Doris</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Chango+Ramírez%2C+Ángel%22">Chango Ramírez, Ángel</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Estrada+García%2C+Lady%22">Estrada García, Lady</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Yugcha+Andino%2C+Germania%22">Yugcha Andino, Germania</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Calderón+León%2C+María+Fernanda%22">Calderón León, María Fernanda</searchLink><relatesTo>3</relatesTo><i> dracalderonleon@hotmail.es</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revista+Medicina%22">Revista Medicina</searchLink>. 2025, Vol. 25 Issue 1, p14-21. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22TYPE+2+diabetes%22">TYPE 2 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22GESTATIONAL+diabetes%22">GESTATIONAL diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22NEONATAL+intensive+care+units%22">NEONATAL intensive care units</searchLink><br /><searchLink fieldCode="DE" term="%22TYPE+1+diabetes%22">TYPE 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22WEIGHT+gain%22">WEIGHT gain</searchLink>
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: Introduction: Gestational diabetes, a common disease in pregnancy, whose prevalence increases in one in six live births worldwide. Materials and methods: A systematic review was developed with the PRISMA 2020 declaration. Results: metformin was superior to insulin in hypoglycemic events. The efficacy, safety of metformin alone or as complementary insulin therapy in pregnancy with gestational diabetes mellitus with diabetes mellitus type 2 reduced maternal weight gain, maternal hypoglycemia, neonatal hypoglycemia, admission to the neonatal intensive care unit and reduction of birth weight 4000 g. Conclusions: Gestational diabetes is related to perinatal morbidity, an increased risk of diabetes and cardiovascular diseases in the future mother and predisposition to childhood obesity in offspring. Metformin reduces the risk of certain maternal and neonatal outcomes compared to insulin therapy [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: Introducción: La diabetes gestacional, enfermedad frecuente en el embarazo, cuya prevalencia aumenta en uno de cada seis nacidos vivos en todo el mundo. Materiales y métodos: Se elaboró una revisión sistemática con la declaración PRISMA 2020. Resultados: metformina fue superior a la insulina en eventos hipoglucémicos. La eficacia, seguridad de la metformina sola o como terapia complementaria a la insulina en el embarazo con diabetes mellitus gestacional con diabetes mellitus tipo 2 redujo el aumento de peso materno, hipoglucemia materna, hipoglucemia neonatal, ingreso a la unidad de cuidados intensivos neonatales y reducción del peso al nacer ≥4000 g. Conclusiones: La Diabetes gestacional se relaciona con morbilidad perinatal, un mayor riesgo de diabetes y enfermedades cardiovasculares en la madre a futuro y predisposición a obesidad infantil en la descendencia. La metformina reduce el riesgo de ciertos resultados maternos y neonatales en comparación con la terapia con insulina. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Revista Medicina is the property of Revista Medicina and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=186116458
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.23878/medicina.v25i1.1240
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 14
    Subjects:
      – SubjectFull: TYPE 2 diabetes
        Type: general
      – SubjectFull: GESTATIONAL diabetes
        Type: general
      – SubjectFull: NEONATAL intensive care units
        Type: general
      – SubjectFull: TYPE 1 diabetes
        Type: general
      – SubjectFull: WEIGHT gain
        Type: general
    Titles:
      – TitleFull: Diabetes gestacional. Una revisión sistemática.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Robles Granda, Eliana
      – PersonEntity:
          Name:
            NameFull: Domo Tomalá, Doris
      – PersonEntity:
          Name:
            NameFull: Chango Ramírez, Ángel
      – PersonEntity:
          Name:
            NameFull: Estrada García, Lady
      – PersonEntity:
          Name:
            NameFull: Yugcha Andino, Germania
      – PersonEntity:
          Name:
            NameFull: Calderón León, María Fernanda
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 13900218
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Revista Medicina
              Type: main
ResultId 1